Literature DB >> 27134862

Hyperuricaemia - A Potential Indicator to Diagnose the Risk of Essential Hypertension.

Chanchal Shrivastav1, Manjinder Kaur2, M L Suhalka3, Suman Sharma1, Abhijit Basu4.   

Abstract

INTRODUCTION: Hypertension has turned out to be the major cause of morbidity among the life style diseases. Studies in human and animal models have documented an independent association of hyperuricaemia with early hypertension. Hyperuricaemia is a modifiable and treatable risk factor, which might reduce the incidence of Essential Hypertension (EHT). AIM: Hence, the present study was designed to find out the association between hyperuricaemia and EHT in the population of Southern Rajasthan as there is a dearth of literature on Indian scenario especially in Rajasthan.
MATERIALS AND METHODS: A cross-sectional, case control study was carried out in the Department of Physiology among 125 subjects; aged 20-50 years of both sexes, which were chosen randomly from Medicine OPD and healthy volunteers. The subjects were broadly divided into two groups (A & B); group A comprised of newly diagnosed cases of EHT (n=75) and group B had healthy normotensive controls (n=50). S. Uric Acid (SUA), Serum creatinine and fasting blood glucose levels were estimated by using the respective kit methods on semi auto-analyser in both groups. S. creatinine and fasting blood glucose levels were estimated to exclude renal disorder and diabetes mellitus respectively. The data was analysed by student t-test, chi-square test and Odds Ratio.
RESULTS: The mean SUA level in group A was significantly higher than group B (6.56 ± 0.76, 4.91 ± 0.97 mg/dl, p<0.001 respectively). 37.33% of patients had hyperuricaemia in group A as compared to 14% in group B (p<0.01, OR=3.66) indicating that a hyperuricaemic individual has 3.66 times more risk of developing EHT as compared to the one with lower value of SUA.
CONCLUSION: The mean SUA level and the frequency of hyperuricaemia was significantly higher in newly diagnosed cases of EHT as compared to healthy controls. Hence, SUA could be useful as a potential indicator for early risk detection of development of EHT.

Entities:  

Keywords:  Preclinical hyperuricaemia; Primary hypertension; Serum uric acid; Southern Rajasthan

Year:  2016        PMID: 27134862      PMCID: PMC4843248          DOI: 10.7860/JCDR/2016/17747.7394

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

1.  Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.

Authors:  Kazuko Masuo; Hideki Kawaguchi; Hiroshi Mikami; Toshio Ogihara; Michael L Tuck
Journal:  Hypertension       Date:  2003-09-02       Impact factor: 10.190

2.  What are the key arguments against uric acid as a true risk factor for hypertension?

Authors:  Richard J Johnson; Laura G Sánchez-Lozada; Marilda Mazzali; Daniel I Feig; Mehmet Kanbay; Yuri Y Sautin
Journal:  Hypertension       Date:  2013-03-04       Impact factor: 10.190

3.  Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.

Authors:  M Mazzali; J Hughes; Y G Kim; J A Jefferson; D H Kang; K L Gordon; H Y Lan; S Kivlighn; R J Johnson
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

4.  Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.

Authors:  Johan Sundström; Lisa Sullivan; Ralph B D'Agostino; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Hypertension       Date:  2004-11-29       Impact factor: 10.190

5.  Uric acid reduction rectifies prehypertension in obese adolescents.

Authors:  Beth Soletsky; Daniel I Feig
Journal:  Hypertension       Date:  2012-09-24       Impact factor: 10.190

6.  Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex.

Authors:  Nathan D Wong; Gaurav Thakral; Stanley S Franklin; Gil J L'Italien; Milagros J Jacobs; Joanna L Whyte; Pablo Lapuerta
Journal:  Am Heart J       Date:  2003-05       Impact factor: 4.749

Review 7.  Uric acid and cardiovascular risk.

Authors:  Daniel I Feig; Duk-Hee Kang; Richard J Johnson
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

8.  Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity.

Authors:  Susumu Watanabe; Duk-Hee Kang; Lili Feng; Takahiko Nakagawa; John Kanellis; Hui Lan; Marilda Mazzali; Richard J Johnson
Journal:  Hypertension       Date:  2002-09       Impact factor: 10.190

Review 9.  Kinetic serum creatinine assays. II. A critical evaluation and review.

Authors:  L D Bowers; E T Wong
Journal:  Clin Chem       Date:  1980-04       Impact factor: 8.327

Review 10.  Chronic hyperuricemia, uric acid deposit and cardiovascular risk.

Authors:  Davide Grassi; Livia Ferri; Giovambattista Desideri; Paolo Di Giosia; Paola Cheli; Rita Del Pinto; Giuliana Properzi; Claudio Ferri
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.